How many studies have been conducted on Nogo Receptor 1?

BiohacksAI has indexed 95 PubMed studies on Nogo Receptor 1. 17% of studies involve human subjects.

What are the main research areas for Nogo Receptor 1?

The primary research domains for Nogo Receptor 1 are 🧠 Learning, 🧠 Memory, 🔬 Oncology. This is based on analysis of 95 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Nogo Receptor 1

A high affinity receptor for myelin-associated inhibitors (MAIs) that include NOGO-A PROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; and MYELIN-ASSOCIATED GLYCOPROTEIN. It is expressed primarily by neurons in the brain and OLFACTORY BULBS. During embryonic development, it is expressed in the PERIPHERAL NERVOUS SYSTEM. It localizes to GROWTH CONES and may inhibit neurite outgrowth following SPINAL INJURY.

95+ PubMed studies analyzed · Evidence Score: 43.6

Research Domains

Nogo Receptor 1 has been studied across 18 research domains including 🧠 Learning, 🧠 Memory, 🔬 Oncology, 🦴 Bone & Joint, 🛡️ Immunity. The primary research focus is 🧠 Learning with 17% of studies addressing this area.

Loading evidence profile...

This evidence profile for Nogo Receptor 1 is generated deterministically from 95 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.